Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.4.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
AY.99.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KT.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.334ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.359ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.302ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.222ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.434ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.467ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.110.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.23 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.9 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.74 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EE.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
DB.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BW.1.1.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BQ.1.1.22NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BE.6NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
KB.4NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
HF.1.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
BG.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
JN.1.42.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BQ.1.1.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.1.517NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.427 (Epsilon)NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.429 (Epsilon)NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.166NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BA.4.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
A.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BF.7.4NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
AY.99.1 (Delta)NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
KT.1.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
JC.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.334NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.359NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.302NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.1.222NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.1.434NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.1.467NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.110.3NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
AY.23 (Delta)NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
AY.9 (Delta)NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
AY.74 (Delta)NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.621.1 (Mu)NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BA.2.5NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BF.7.5NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BF.32NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used